Jiayuan Science and Technology Co.,Ltd.

SZSE:301117 Stock Report

Market Cap: CN¥3.0b

Jiayuan Science and TechnologyLtd Balance Sheet Health

Financial Health criteria checks 4/6

Jiayuan Science and TechnologyLtd has a total shareholder equity of CN¥1.3B and total debt of CN¥1,000.0K, which brings its debt-to-equity ratio to 0.08%. Its total assets and total liabilities are CN¥1.4B and CN¥122.5M respectively.

Key information

0.08%

Debt to equity ratio

CN¥1.00m

Debt

Interest coverage ration/a
CashCN¥405.21m
EquityCN¥1.29b
Total liabilitiesCN¥122.49m
Total assetsCN¥1.42b

Recent financial health updates

No updates

Recent updates

Jiayuan Science and Technology Co.,Ltd.'s (SZSE:301117) P/S Is Still On The Mark Following 33% Share Price Bounce

Sep 30
Jiayuan Science and Technology Co.,Ltd.'s (SZSE:301117) P/S Is Still On The Mark Following 33% Share Price Bounce

Why Investors Shouldn't Be Surprised By Jiayuan Science and Technology Co.,Ltd.'s (SZSE:301117) 26% Share Price Surge

Jul 29
Why Investors Shouldn't Be Surprised By Jiayuan Science and Technology Co.,Ltd.'s (SZSE:301117) 26% Share Price Surge

What You Can Learn From Jiayuan Science and Technology Co.,Ltd.'s (SZSE:301117) P/S

May 30
What You Can Learn From Jiayuan Science and Technology Co.,Ltd.'s (SZSE:301117) P/S

Returns On Capital Signal Tricky Times Ahead For Jiayuan Science and TechnologyLtd (SZSE:301117)

Feb 27
Returns On Capital Signal Tricky Times Ahead For Jiayuan Science and TechnologyLtd (SZSE:301117)

Financial Position Analysis

Short Term Liabilities: 301117's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥120.8M).

Long Term Liabilities: 301117's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥1.7M).


Debt to Equity History and Analysis

Debt Level: 301117 has more cash than its total debt.

Reducing Debt: 301117's debt to equity ratio has reduced from 15.4% to 0.08% over the past 5 years.

Debt Coverage: 301117's operating cash flow is negative, therefore debt is not well covered.

Interest Coverage: Insufficient data to determine if 301117's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies